Published at May 1, 2020, in The 420 ReportThe final week in April has proven to be a big week in the cannabis sector, with several global milestones expected in May.
The expanded range includes imported white-labelled medicines, and medicines produced by the THC Global using imported crude cannabis extract.
The company is also set to begin building one of the world’s largest medicinal cannabis operations in the central Victorian city of Shepparton.
The WaferiX® delivery overcomes three common problems with the delivery of medicinal cannabis – lack of fixed unit dosages, inconsistent absorption and variable or poor bioavailability.
“While these developments add to our growing list of intellectual property, these are much more than technologies that will sit on a shelf,” commented Arman Tabatabaei, CEO of Cannabis Global.